The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
People who have a transient ischemic attack (TIA) should get aggressive treatment to help protect cognitive health, a new study suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback